Type 1 and type 2 myocardial infarction in a sub-Saharan Africa population: Data from the REACTIV survey

H. Yao,C. Touré,A. Ekou,Y. Cottin,M. Zeller,A. Putot,R. N’Guetta

DOI: https://doi.org/10.1016/j.acvd.2023.10.040

IF: 3.196

2024-01-01

Archives of Cardiovascular Diseases

Abstract:Introduction Little is known about type 2 myocardial infarction (T2MI) in sub Saharan Africa. Objective From a large observational acute coronary syndrome registry in Côte d’Ivoire, we aimed to address incidence, clinical, management and in-hospital outcomes of T2MI compared with T1MI patients. Method We carried out a cross-sectional monocentric study using data from the REgistre des InfArctus de CôTe d’IVoire (REACTIV). For the present study, all MI patients included between 2018 and 2022 who underwent coronary angiography were considered. Acute MI was diagnosed and MI cases were adjudicated into T1MI and T2MI, based on criteria defined in the fourth UDMI. For each patient, sociodemographic and anthropometric data (age, sex, body mass index (BMI)), clinical data (cardiovascular (CV) risk factors and history, presentation), paraclinical data and in-hospital outcomes were collected. Results Among 541 patients hospitalized for MI, coronary angiography was not performed in 87 patients. Finally, 441 met the definition of T1MI or T2MI in the study population. T2MI accounted for 14.1% of cases (62/441). When compared with patients with T1MI, T2MI were slightly younger (54 versus 58 years), with a higher rate of women. Classical CV risk factors (hypertension, diabetes, dyslipidemia, and smoking) were more frequent in T1MI. T2MI patients had more frequent history of HF or LV dysfunction (p =0.025). Prior or on admission ECG AF/flutter were much more common in T2MI (p <0.001). Compared to T1MI, T2MI had less severe CAD, with less frequent multivessel disease (p <0.001). P2Y12 inhibitors were more likely to be prescribed in T1MI (p <0.001). By contrast, vitamin K antagonists (VKA) were used only in T2MI patients. The main triggering factors for T2MI (Figure 1) were coronary embolism (24.2%), severe hypertension±LVH (22.6%) and tachy-arrythmia (16.1%). Anemia was rarely involved (3.2%). In-hospital event rates were low whatever MI types. In agreement with history and ECG findings, AF/flutter, and stroke showed only a non-significant trend toward higher rate in T2MI. Overall hospital mortality was 2.3%. Albeit without significant difference, death rates in T1MI trend to be higher than in T2MI. Conclusion Our study showed significant disparities concerning T2MI clinical characteristics, angiographic features and in-hospital outcomes compared to Western studies.

cardiac & cardiovascular systems